Bcl-2 抑制剂venetoclax 在髓系肿瘤中的治疗进展
罗兴春， 朱玉， 冯悦， 刘蓓 - 中国肿瘤临床, 2020 - cjco.cn
… Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in
acute myeloid leukemia models[J]. Haematol, 2020, 105(3):697-707. [45] Aboudalle I, …
acute myeloid leukemia models[J]. Haematol, 2020, 105(3):697-707. [45] Aboudalle I, …
[PDF][PDF] 急性髓系白血病耐药相关信号通路的研究进展
张静， 何欢， 曾雪倩， 王晓玲， 汪涛 - 河北医学, 2021 - hbyxzzs.cn
… 性ꎬ与激活MAPK通路有关ꎮ ERK抑制剂Cobimetinib 和Bcl-2通路抑制剂… Concomitant targeting
of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia …
of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia …